Because CLO is a selective estrogen receptor modulator, it is used in estrogen receptor positive breast cancer prevention and treatment.7 Also, it is reported that CLO prohibits cellular proliferation of breast cancer cells.8 CLO exhibited antitumor activity in the early stage of a clinical trial during the treatment of advanced breast cancer.9 The gene discussed is ESR1; the disease is breast carcinoma.